Transition from intravenous to subcutaneous insulin: Effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome

Diabetes Care

Volumn 34, Issue 7, 2011, Pages 1445-1450

  Avanzini, Fausto ^a,b   Marelli, Giuseppe ^a   Donzelli, Walter ^a   Busi, Giovanna ^a   Carbone, Stefania ^a   Bellato, Laura ^a   Colombo, Elena Lucia ^a   Foschi, Roberto ^b   Riva, Emma ^b   Roncaglioni, Maria Carla ^b   De Martini, Mario ^a  

^a DESIO HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC PATIENT; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT TRANSPORT; PREDICTION; PROSPECTIVE STUDY; TREATMENT RESPONSE; EATING; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PATIENT CARE; STANDARD; SUBCUTANEOUS DRUG ADMINISTRATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CLINICAL PROTOCOLS; DIABETES COMPLICATIONS; EATING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT CARE TEAM; PROSPECTIVE STUDIES;

EID: 80054698640     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2023     Document Type: Article

References (25)

1. Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006;355:1903-1911 (Pubitemid 44664648)
2. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists; American Diabetes Association. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009;32:1119-1131
3. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care 2010;33(Suppl. 1):S11-S61
4. Associazione Medici Diabetologi - SocietàItaliana di Diabetologia. Standard Italiani per la Cura del Diabete Mellito 2009-2010. Torino, Edizioni Infomedica, 2010
5. Rydén L, Standl E, Bartnik M, et al. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007;28:88-136 (Pubitemid 46137814)
6. Deedwania P, Kosiborod M, Barrett E, et al. American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008;117:1610-1619 (Pubitemid 351440650)
7. Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol 2006;98: 557-564 (Pubitemid 44162888)
8. DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract 2006;12:491-505 (Pubitemid 46456036)
9. Czosnowski QA, Swanson JM, Lobo BL, Broyles JE, Deaton PR, Finch CK. Evaluation of glycemic control following discontinuation of an intensive insulin protocol. J Hosp Med 2009;4:28-34
10. Weant KA, Ladha A. Conversion from continuous insulin infusions to subcutaneous insulin in critically ill patients. Ann Pharmacother 2009;43:629-634
11. Schmeltz LR, DeSantis AJ, Schmidt K, et al. Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia. Endocr Pract 2006;12:641-650
12. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 2004; 27:461-467 (Pubitemid 38174072)
13. Avanzini F, Marelli G, Donzelli W, et al.; DDD study group. Hyperglycemia during acute coronary syndrome: a nurse-managed insulin infusion protocol for stricter and safer control. Eur J Cardiovasc Nurs 2009; 8:182-189
14. Bantle JP, Wylie-Rosett J, Albright AL, et al.; American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008;31(Suppl. 1):S61-S78
15. Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004;10(Suppl. 2):71-80
16. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655
17. Umpierrez GE, Smiley D, Zisman A, et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial). Diabetes Care 2007;30:2181-2186 (Pubitemid 47359011)
18. Umpierrez GE, Smiley D, Jacobs S, et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery). Diabetes Care 2011;34:256-261
19. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007;35: 2262-2267 (Pubitemid 47476221)
20. Svensson AM, McGuire DK, Abrahamsson P, Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 2005;26: 1255-1261 (Pubitemid 41435454)
21. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 2008;117:1018-1027
22. Brunkhorst FM, Engel C, Bloos F, et al.; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-139
23. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35:1738-1748
24. Finfer S, Chittock DR, Su SY, et al.; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297
25. Skyler JS, Bergenstal R, Bonow RO, et al.; American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation 2009;119:351-357